Search results for "Osteoporosis"
Denosumab associated with hypocalcemia requiring treatment in patients with advanced CKD
The risk of hypocalcemia requiring ED or hospital care in patients taking denosumab appeared to increase with worsening chronic kidney disease (CKD) stage, with dialysis dependence, and with CKD-mineral and bone disorder, an analysis found.
https://immattersacp.org/weekly/archives/2024/11/19/1.htm
19 Nov 2024
New ACP paper reviews performance measures for osteoporosis
Of the six osteoporosis performance measures relevant to internal medicine physicians, only one is valid at three levels of attribution, i.e., individual physician, group practice, and health plan, an ACP assessment found.
https://immattersacp.org/weekly/archives/2023/10/10/6.htm
10 Oct 2023
Closing the gap on osteoporosis
A new clinical guideline from ACP focuses on pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults.
https://immattersacp.org/archives/2023/05/closing-the-gap-on-osteoporosis.htm
1 May 2023
ACP issues new osteoporosis guidance
The new clinical guideline from the College updates its 2017 recommendations on pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults.
https://immattersacp.org/weekly/archives/2023/01/03/1.htm
3 Jan 2023
Traumatic fractures associated with subsequent fracture risk in postmenopausal women
Data from the Women's Health Initiative suggest that either a high-trauma or low-trauma fracture warrants evaluation for osteoporosis and counseling about fracture risk.
https://immattersacp.org/weekly/archives/2021/06/15/4.htm
15 Jun 2021
Bisphosphonates associated with lower fracture risk, not associated with mortality
Lower mortality rates linked to bisphosphonates in previous observational studies might be due to direct biological effects of treatment, authors of a recent meta-analysis noted.
https://immattersacp.org/weekly/archives/2019/08/27/4.htm
27 Aug 2019
Osteoporosis screening, treatment uncommon after stroke
Among 16,581 patients, 5.1% underwent poststroke bone mineral density testing and 15.5% received fracture prevention treatment within one year.
https://immattersacp.org/weekly/archives/2019/04/30/4.htm
30 Apr 2019
Guideline recommends pharmacologic treatment of osteoporosis in postmenopausal women at high fracture risk
Bisphosphonates are recommended for initial treatment, although ibandronate is not recommended for reducing nonvertebral or hip fracture risk, the clinical practice guideline from the Endocrine Society stated.
https://immattersacp.org/weekly/archives/2019/04/02/4.htm
2 Apr 2019
Osteoporosis treatment often not started after hip fracture in elderly patients, study finds
The study found a continuous decline in starting osteoporosis treatment after hip fracture from 2004 to 2015, as well as a clinically meaningful reduction in rate of subsequent nonvertebral fracture in patients who did begin treatment versus those who did not.
https://immattersacp.org/weekly/archives/2018/07/24/4.htm
24 Jul 2018
ACR guideline recommends customized approach for prevention of glucocorticoid-induced osteoporosis
Recommendations include treating only with calcium and vitamin D in adults at low fracture risk, and adding an additional osteoporosis medication (oral bisphosphonate preferred) in adults at moderate to high fracture risk.
https://immattersacp.org/weekly/archives/2017/06/20/2.htm
20 Jun 2017
ACP strongly recommends generic bisphosphonates, denosumab to prevent fractures in women with osteoporosis
The guideline focuses on the comparative benefits and risks of short- and long-term drug treatments for low bone density or osteoporosis, including prescriptions, calcium, vitamin D, and estrogen.
https://immattersacp.org/weekly/archives/2017/05/09/1.htm
9 May 2017
Benefits, harms of osteoporosis medications unclear for patients with CKD
Among several gaps in medical knowledge, there was conflicting or insufficient evidence of the effectiveness of bisphosphonates on fractures and safety in transplant recipients and patients with chronic kidney disease.
https://immattersacp.org/weekly/archives/2017/04/11/4.htm
11 Apr 2017
Act early to counter rise in osteoporosis
Recent studies indicate that late-life bone resiliency has been eroding, and newly released guidelines suggest diagnostic and treatment strategies to counteract that slide among women.
https://immattersacp.org/archives/2017/01/osteoporosis-care.htm
1 Jan 2017
Repeat bone mineral density tests during osteoporosis treatment may help identify women at increased fracture risk, study finds
Monitoring bone mineral density in routine clinical practice may identify women with a suboptimal response to osteoporosis treatment who would benefit from closer follow-up, researchers noted.
https://immattersacp.org/weekly/archives/2016/07/19/1.htm
19 Jul 2016